Interestingly, we found that CTCs were increased in the FOXD1-vehicle group compared to the control-vehicle group as early as 3 weeks after cell inoculation, indicating that FOXD1 promoted CTC formation from the early stages of BC (Fig. 6B). Here, FOXD1 is linked to breast cancer.